Suspension Palatoplasty for Obstructive Sleep Apnea- A Preliminary Study
- PMID: 29523819
- PMCID: PMC5844908
- DOI: 10.1038/s41598-018-22710-1
Suspension Palatoplasty for Obstructive Sleep Apnea- A Preliminary Study
Abstract
Suspension palatoplasty, a new surgical technique to treat obstructive sleep apnea (OSA), has been developed to correct the retropalatal obstruction in patients with small tonsils (grade I/II) and anterior-posterior palatal (A-P) obstruction. The objecteive of this preliminary study was to investigate the effectiveness and change in retropalatal airway dimensions after suspension palatoplasty. This retrospective case series study included 25 consecutive male adults with OSA. Unique technical features of suspension palatoplasty are exposure of pterygomandibular raphe and suspension of palatopharyngeus muscle to the raphe. Six months after suspension palatoplasty, apnea-hyponea index significantly reduced from 39.8 to 15.1 (effect size = 1.6). None experienced postoperative bleeding and velopharyngeal insufficiency 1 month following surgery. Subjective snoring severity (visual analogue scale) and daytime sleepiness (the Epworth Sleepiness Scale) significantly improved (8.7 vs 2.0 and 10.2 vs 4.9, respectively). A-P dimension of the retropalatal airspace widened significantly on perioperative endoscopy (23.0 units vs 184.6 unites) as well as posterior air space in cephalometry (7.6 mm vs 10.2 mm). Our preliminary findings show that suspension palatoplasty seems to be an effective OSA surgery in the specific patient population with minimal complications, however, further studies including a large number of patients are required to confirm the findings.
Conflict of interest statement
Dr. Eric J. Kezirian’s research has been funded by Inspire Medical Systems. The funding source has no role in the conceptualization, design, data collection, analysis, decision to publish, and preparation of the manuscript. He also has received compensation as a member of the advisory board, consultant, and shareholder of ReVENT Medical, Nyxoah, Pillar Palatal, Gerard Scientific, Split Rock Scientific, and Cognition Life Sciences; a member of the advisory board of Berendo Scientific; and a patent ownership of Magnap. Drs. Hsueh-Yu Li, Li-Ang Lee, and Meiho Nakayama declare no potential conflict of interest.
Figures
References
-
- Medicine, A. A. O. S. In American Academy of Sleep Medicine. The International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual: 52–58 (American Academy ofSleep Medicine, 2001).
-
- Esclamado RM, Glenn MG, McCulloch TM, Cummings CW. Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome. Laryngoscope. 1989;99:1125–1129. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
